1. Introduction {#s0005}
===============

One of the important challenges for contemporary biology and medicine is to understand the relationship between human diseases and underlying cellular mechanisms ([@bib7], [@bib29], [@bib39], [@bib41], [@bib43], [@bib46], [@bib53], [@bib59]). During the past decade, many efforts have been dedicated to identifying disease-related genes, proteins and metabolites, which directly or indirectly interact through genetic or physical behavior ([@bib1], [@bib2], [@bib3], [@bib9], [@bib10], [@bib28], [@bib80]). In recent years, researchers concentrate on the embryo development in disease process ([@bib33], [@bib57], [@bib61], [@bib67]). Some evidences suggest that cellular mechanisms during the embryogenesis are similar with what occur in some disease process such as cancer ([@bib23], [@bib30], [@bib47], [@bib52], [@bib58]). For instance, Navarro et al. reviewed some complex relationships between embryo development and cancer. However, it is increasingly comprehended that those gene-by-gene or protein-by-protein approaches, even genome-wide studies, although tremendously successful, are far from achievement, because the complicated cellular mechanisms are executed through an intricate network comprising regulatory and protein interaction ([@bib1], [@bib9], [@bib22], [@bib83]). Exploring such systematic relationship among cellular networks and disease patterns could possibly open a brand-new boulevard for understanding the interactome, and may help discover underlying mechanisms of diseases ([@bib11], [@bib25], [@bib31], [@bib44], [@bib46]).

More investigations have focused on network-based approaches to study human diseases with the increasing high-throughput data ([@bib26], [@bib27], [@bib31], [@bib37], [@bib44], [@bib45], [@bib66], [@bib70]). For instance, [@bib31] constructed the disease phenome network (human disease network, HDN) and disease genome network (disease gene network, DGN), using disease-gene association pairs extracted from the Online Mendelian Inheritance in Man (OMIM) database. Thus, [@bib44] created a metabolic disease network (MDN), and explained that metabolic diseases trend to be co-morbid in the population if the enzymes and their related diseases are linked through metabolic pathways. Recently, [@bib70] demonstrated a close association between aging and diseases.

Using graphical approaches to study biological problems can provide an intuitive picture or useful insights for helping analyzing complicated mechanisms in these systems, as demonstrated by many previous studies on a series of important biological topics, such as enzyme-catalyzed reactions ([@bib12], [@bib13], [@bib17], [@bib82]), protein folding kinetics ([@bib14]), inhibition of HIV-1 reverse transcriptase ([@bib4], [@bib5], [@bib6]), inhibition kinetics of processive nucleic acid polymerases and nucleases ([@bib20]), drug metabolism systems ([@bib15]), analysis of DNA sequence ([@bib79], [@bib81]) and protein sequence evolution ([@bib73]). Meanwhile, the \'wenxiang diagram\' ([@bib21]) has been used to investigate protein--protein interactions([@bib18], [@bib64]), and the graphical representation utilized to identify the hub proteins from complicated network systems ([@bib32], [@bib36], [@bib62]). Recently, the \'cellular automaton image\' ([@bib72]) has also been applied to study hepatitis B viral infections ([@bib74]), HBV virus gene missense mutation ([@bib78]), and visual analysis of SARS-CoV ([@bib71]), as well as representing complicated biological sequences ([@bib77]), and helping to identify various protein attributes ([@bib75], [@bib76]).

In this paper we focus on embryo development, which is one of the important processes of human being and previous studies have investigated relationship between embryo development and disease such as cancer ([@bib24], [@bib42], [@bib56], [@bib65], [@bib68]). Research on embryo development is beneficial to comprehend the nature of disease by integrating disease and embryo development information at a network level. We note that their relationships have been pointed out for a long time, but seldom been researched from the systems level. Here we emphasize the intricate relationships between embryo development and disease since the embryo development process is gradual development process from zygote to adult cell and this process is similarity with some of disease such as cancer, in which the process is reversed from adult cell to cancer stem cell ([@bib65], [@bib68]). We tried to use the embryo development genes and disease genes to highlight the intricate correlations between embryo development and disease process systematically. We analyzed the association between embryo development genes and disease genes from PPI network and reconstructed a disease-embryo development network (DEN) and analyzed its topological properties. Then according to the relationship between embryo development genes and disease genes in different biological levels, we divided the diseases into three groups: embryo development high-related disease (EHD), embryo development medium-related disease (EMD) and embryo development low-related disease (ELD). In addition, we compared the differences between the three groups of disease genes from network centrality, functional enrichment and the proportion of essential genes. And we also compared the closeness centrality of embryo development genes in the network of three groups of diseases.

2. Materials and methods {#s0010}
========================

2.1. Datasets {#s0015}
-------------

### 2.1.1. The human embryo development genes {#s0020}

A list of human embryo development genes was extracted from two sources. Firstly, we obtained the gene set involving the word "embryo" and "development" in the Entrez Gene description field (downloaded from the Entrez Gene website [ftp://ftp.ncbi.nih.gov/gene/DATA/GENE_INFO/mammalia/Homo_sapiens.gene_info.gz](http://ftp.ncbi.nih.gov/gene/DATA/GENE_INFO/mammalia/Homo_sapiens.gene_info.gz) on June 30, 2010). Secondly, we obtained the gene set annotated the Gene Ontology functional terms which include the descriptive word "embryo" and "development" (downloaded from <http://www.geneontology.org> on June 30, 2010). We finally got 643 genes in which 516 genes are contained in the human PPI network.

### 2.1.2. Disease genes and classification of diseases {#s0025}

The disease genes and their classification were obtained from previous study ([@bib31]), which were manually classified into 22 disease classes based on the physiological system affected. Totally, there are 1777 disease genes in which 1345 are involved in the human PPI network. Particularly, some diseases, which have multiple clinical features, were marked "multiple", and some other diseases were labeled "unclassified" if they could not be assigned to a clear disease class. "Multiple" class disease represents that the disease has distinct multiple clinical features or has no evidence to show which systems the disease affect. And "unclassified" class disease represent that the disease cannot be classified clearly. Then we constructed the DEN with all 22 diseases class, but did not consider the "multiple" class and "unclassified" class in the following discussion.

### 2.1.3. Protein--protein network and essential genes {#s0030}

Human protein--protein interaction (PPI) network is obtained from HPRD Release 9 (<http://www.hprd.org>, downloaded on June 30, 2010). Until the download date, the network involved 9611 proteins and 39,118 interactions. Essential genes were downloaded from the Mouse Genome Informatics (<http://www.informatics.jax.org>, downloaded on August 2, 2010). We got 2661 essential genes in which 2191 are in HPRD.

2.2. Measures {#s0035}
-------------

### 2.2.1. Closeness centrality of nodes in network {#s0040}

We used closeness centrality (CC) to measure the centrality of nodes in a given network. CC is defined by$$c_{v} = \frac{N - 1}{\sum_{u \in v}{d(v,u)}}$$where $v$ is the node in a given network, *N* is the total number of nodes in the network and $d(v,u)$ represents the shortest path between node $v$ and $u$.

### 2.2.2. *p*-Value by overlapping {#s0045}

We used this formula to calculate the significant *p*-value of gene sharing, interaction partner of PPI network, co-regulated by microRNAs and TFs. *p*-values were calculated by the following formula:$$\left. P(X = k \middle| N,m,n) = 1 - \sum\limits_{i = 0}^{k}\frac{\left( \begin{array}{l}
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Consider that a set containing *M* elements has two subsets S1 and S2 with *K* and *N* elements, respectively. We calculate the probability that there are *x* overlapping elements with hypergeometric distribution.

### 2.2.3. Degree-conserved network permutation {#s0050}

To prove whether embryo development genes tend to connect with disease genes, we performed degree-conserved network permutation for embryo development genes as following steps:Step 1: We generated pseudo-embryo development gene sets for every embryo development genes, where the gene in the pseudo-embryo development gene sets has the same degree with corresponding embryo development gene in the PPI network.Step 2: For the set of 516 embryo development genes, we randomly chose a gene from its corresponding pseudo-embryo development gene sets as pseudo-embryo development gene. Finally 516 pseudo-embryo development genes were generated. We used these pseudo-embryo development genes and disease genes to calculate the max connected components of pseudo-disease embryo development network.Step 3: We repeated Step 2 1000 times and generated the degree-conserved pseudo-disease embryo development network.

We used the 1000 sets of pseudo-disease-embryo development network to substitute the disease-embryo development network as random control and calculated the significance of max connected components.

### 2.2.4. Disease co-morbidity index {#s0055}

In this paper, we use $\Phi$ index to measure disease co-morbidity and try to find out what the role of embryo development genes in disease co-morbidity. For disease *i* and disease *j*, the disease co-morbidity index was defined as$$\Phi_{ij} = \frac{NN_{ij} - N_{i}N_{j}}{\sqrt{N_{i}N_{j}(N - N_{i})(N - N_{j})}}$$where $\Phi_{ij}$ is co-morbidity index of disease *i* and *j*. $N = {13},{039},{018}$ elderly patients and *N* ~*i*~ represent the number of patients, who catch disease *i*.

3. Results {#s0060}
==========

3.1. Construction of embryo development-related human disease network {#s0065}
---------------------------------------------------------------------

We used embryo development genes and disease genes to construct a disease-embryo development network (DEN). The association pairs between diseases and genes were from the Online Mendelian Inheritance in Man (OMIM) ([@bib34], [@bib35]; Supplementary [Table S1](#s0085)). Human embryo development genes were extracted from Gene Ontology (GO) ([@bib8]) and Entrez Gene ([@bib48]) by the keywords "embryo" and "development" (Supplementary [Table S2](#s0085)). We generated the network, in which nodes represent known embryo development genes and disease genes, and two genes are connected if they associate with each other in Human Protein Reference Database (HPRD; [@bib55]), and then extracted the maximum connected component of network as DEN ( [Fig. 1](#f0005){ref-type="fig"}). In the DEN, nodes with black border represented embryo development genes, and the color of the nodes represents the disease class ([@bib31]). In addition, if a disease gene belongs to more than one category, it will be labeled as "MD".Fig. 1The disease embryo development network (DEN). A protein--protein interacting network connects the disease genes and embryo development genes. In the DEN, disease genes are colored based on the disease categories to which it belongs, and embryo development genes are colored in white with blank border. A gene belonging to multi-disease class is labeled by "MD", and colored by pink. The size of each node is proportional to the number of interactions in the DEN.

If the embryo development and disease processes are related to the cellular mechanisms, then embryo development genes and disease genes should be connected with each other in the network. As shown in [Fig. 1](#f0005){ref-type="fig"}, DEN contains 1257 nodes and 3617 edges, and the number of nodes and edges are significantly larger than random (*p*-values, 3.5e−3 for nodes and 3.6e−7 for edges, were calculated by 1000 degree-conserved network permutations, as shown in [Fig. 2](#f0010){ref-type="fig"}D and E). This indicates that embryo development genes and disease genes tend to connect with each other.Fig. 2The global topological properties of disease embryo development network (DEN). (A--C) Basic network features of disease embryo development network (DEN). (D) The number of nodes in DEN, which is significantly larger than that of degree-conserved random networks with *p*-value 3.5e−3. (E) The number of edges in DEN, which is significantly larger than that of degree-conserved random networks with *p*-value 3.6e−7. The process of generating the degree-conserved random network is depicted in [Section 2](#s0010){ref-type="sec"}.

In the DEN, the degree of nodes followed power-law distribution ($P(k) \propto k^{- 1.66}$; [Fig. 2](#f0010){ref-type="fig"}A), which indicates that the DEN is a scale free network, and can still maintain its connectivity, when a gene is removed randomly. Moreover, the average degree of embryo development genes is 7, which is larger than the average degree of disease genes 5.6 with a *p*-value 0.02 in the DEN (Wilcoxon rank sum test). Also, the average degree of genes, which are related to both embryo development and diseases, is 8.9, and higher than that of all genes 5.8 with a *p*-value 1.4e−3 in the network (Wilcoxon rank sum test). The results suggest that the embryo development genes may play an important role in the DEN.

Additionally, we calculated the clustering coefficient and topological coefficient of the DEN. In the theory of Barabasi AL and Oltvai ZN ([@bib9]), the clustering coefficient measured the tendency of nodes to form clusters or groups in the network, and the topological coefficient is to describe the extent to which the node shares interaction with the other in the network. As shown in [Fig. 2](#f0010){ref-type="fig"}B, clustering coefficient of the node in DEN reduces with the increase the degree of node, implying the neighbors of high degree node do not tend to connect with each other, and DEN is a hierarchical network. In addition, the topological coefficient decreases with the link of nodes (see [Fig. 2](#f0010){ref-type="fig"}C). It obviously shows that either embryo development or disease hub genes do not share common interaction partners. We then used closeness centrality to measure which type of nodes are more 'central' in the network and found that the mean closeness centrality value of embryo development genes is larger than that of disease genes (*p*-value 8.0e−6).

3.2. Closeness between embryo development and diseases in many biological levels {#s0070}
--------------------------------------------------------------------------------

To explore the relationship between embryo development and diseases, we firstly calculated the number of overlapping genes between them. 153 out of 516 embryo development genes in the PPI network are verified to be associated with some disease classes, significantly higher than expected (*p*-value \<1.0e−20), indicating the close connection between embryo development and diseases (Supplementary [Figure S1A](#s0085)). We then chose all human genes as a background set to recalculate the intersection between embryo development and diseases genes, and found that the count of overlapping genes between them are obviously higher than expected with *p*-value less than 1.0e−30 (Supplementary [Figure S1B](#s0085)). In addition, we checked the link between embryo development and diseases genes. In total 39,118 edges in the PPI network, there are 858 edges belong to embryo development genes interactions, and 2304 edges belong to diseases gene interactions. The number of interactions between nodes which belong to both embryo development and disease is 152, three times as many as expected 50 (Supplementary [Figure S1D](#s0085)).

The result of above shows indeed the close relationship between embryo development and disease, but is that all types of diseases relate to embryo development process? To answer this question, we calculated the overlapping between embryo development and all disease classes from different biological levels, including gene sharing, interaction partner of PPI network, post-transcriptional modification by microRNAs and transcriptional regulation by transcription factors (TF).

The significance of overlapping between embryo development genes and disease genes is shown in [Fig. 3](#f0015){ref-type="fig"}A. Ten diseases, including cancer, developmental disorder etc., are significantly related with embryo development (*p*\<0.05, see [Section 2](#s0010){ref-type="sec"}). Then we checked the association between disease classes and embryo development by calculating the percentage of interaction partners in the human PPI network. The result indicates that eleven disease classes tend to associate with embryo development (see [Fig. 3](#f0015){ref-type="fig"}B). Furthermore, we investigated co-regulated relationship between disease classes and embryo development. As shown in [Fig. 3](#f0015){ref-type="fig"}C and D, four classes of disease and embryo development are co-regulated by microRNA; two classes of disease and embryo development are co-regulated by TF (see [Section 2](#s0010){ref-type="sec"}).Fig. 3The closeness between embryo development and disease in many different biological levels. (A--D) Bar graph to show the statistical significance of closeness between embryo development and disease in gene overlapping (A), interacting partner of human PPI network (B), sharing microRNA (C) and sharing TF (D). Refer to [Section 2](#s0010){ref-type="sec"} for details. (E) Detailed closeness in many ways. According to the number of significant closeness in different biological level, all kinds of disease are categorized into three groups of diseases. High-related embryo development disease (red shadow), which is significant in more than three levels. Medium-related embryo development disease (green shadow), which is significant in two levels. And low-related embryo development disease (blue shadow), which is significant in less than one level. "NaN" represents that the disease classed are not enriched in any of the microRNAs.

3.3. The difference among three groups of diseases {#s0075}
--------------------------------------------------

If there are close relationships between embryo development and some classes of diseases, the closeness between embryo development genes and diseases genes will be reflected in different biological levels. In our study, some kinds of disease show unequal closeness with embryo development in different biological levels. So we divided all disease classes into three groups, as shown in [Fig. 3](#f0015){ref-type="fig"}E, embryo development high-related disease (EHD), medium-related disease (EMD) and low-related disease (ELD), according to the closeness with embryo development in different biological levels. From previous investigations, cancer has shown close relationship with embryo development in many aspects ([@bib38], [@bib40], [@bib42], [@bib51], [@bib52], [@bib68]). And as results shown, cancer has very better significance than other kinds of disease in each level, which is consistent with previous investigations. Also, skeletal diseases are significant in gene overlapping and interact pattern level and some research support it ([@bib49], [@bib60]). But some of them, like metabolic disease, show few or even none relationship with embryo development. Anyway, we combined different *p*-values in each level to classify the disease and analyzed the difference between them.

Firstly, the comparison of the closeness centrality among them in the human PPI network shows that the EHD genes are central in human PPI network, but EMD genes and ELD genes are not. As shown in [Fig. 4](#f0020){ref-type="fig"}A, EHD genes have a significantly higher closeness centrality (0.2697) than EMD genes (0.2493) and ELD genes (0.2423) with *p*-value 3.1e−11 and 3.0e−21, respectively. We also compared the percentage of essential genes in three groups, and found that 60.8% of EHD genes are essential genes, which is significantly higher than 50.4% of EMD genes (*p*-value 7.1e−3) and 38.9% of ELD genes (*p*-value 1.6e−8).Fig. 4The difference among EHD, EMD and ELD in network closeness centrality. (A) The comparison of network closeness centrality among three groups of disease in human PPI network. (B) The difference of network closeness centrality of embryo development genes in the network of three groups of diseases genes.

Secondly, we performed a GO enrichment to analyze the biological functions of EHD genes, EMD genes and ELD genes. As shown in [Table 1](#t0005){ref-type="table"}, EHD genes are significantly enriched in DNA binding and cell cycle phase; EMD genes are significantly enriched in negative regulation of blood pressure and cell differentiation; and ELD genes are enriched in cellular carbohydrate metabolic process, adaptive immune response, etc. Also, we compared the closeness centrality of embryo development genes in the network which constructed by three groups of genes respectively. For each of the three groups of diseases, networks are constructed in which two genes are connected if they associate in HPRD. As shown in [Fig. 4](#f0020){ref-type="fig"}B, the median of closeness centrality of embryo development genes in network of EHD is 0. 3249, and significant higher than that in network of EMD which is 0.1681 (*p*-value 1.2e−3, rank sum test) and ELD which is 0.1909 (*p*-value 3.0e−3 rank sum test). This indicates that embryo development genes tend to be the central of EHD network.Table 1Different GOA enrichments among EHD genes, EMD genes and ELD gene.**GO-IDHighMediumLowDescription*****p*****-value*****p*****-value*****p*****-value3676**6.9e−8--2.1e−6 (under)Nucleic acid binding**5634**9.3e−11--1.3e−5 (under)Nucleus**3690**2.3e−12\>0.01\>0.01Double-stranded DNA binding**22403**7.2e−10\>0.01\>0.01Cell cycle phase**5654**1.6e−8\>0.01\>0.01Nucleoplasm**45776**\>0.014.3e−11\>0.01Negative regulation of blood pressure**7404**\>0.014.7e−9\>0.01Glial cell differentiation**6575**\>0.014.7e−7\>0.01Amino acid derivative metabolic process**55072**\>0.01\>0.011.7e−19Cellular carbohydrate metabolic process**9056**\>0.01\>0.015.8e−13Catabolic process**2250**\>0.01\>0.011.1e−14Adaptive immune response[^2]

Finally, we used BLAST alignment sequence program to investigate the similarity of protein sequences between embryo development genes and three types of disease genes. With *E*-value less than 1.0e−10, the mean alignment sequence score of EHD genes with embryo development genes is 232, significantly higher than EMD genes (score=181, with *p*-value 4.2e−54) and ELD genes (score=175, with *p*-value 1.5e−69). And the mean alignment sequence score of EMD genes is also high than ELD genes with *p*-value 3.8e−4. Additionally, we recalculated the same process with *E*-value less than 1.0e−5, and the mean alignment sequence score of EHD genes is also significantly higher than other types of disease genes. The results indicate that the EHD genes have more similarity with embryo development genes at sequence similarity.

4. Conclusion and discussion {#s0080}
============================

There is an expectation for clinicians and medical researchers to explore the relationship between embryo development and diseases, and a great deal of works have been done for it. Here we constructed the disease-embryo development network for the first time, and investigate the relationship between embryo development and disease. Our results demonstrate that there are close relationships between disease genes and embryo development genes from the perspective of network, which supplies new biological evidences for disease studies. Also, we divided all diseases into three groups according to the closeness with embryo development and compared the differences among them including closeness of PPI network, enrichment biological function, percentage of essential genes and protein sequence similarity. In our results, cancer, developmental and connective tissue diseases show strong correlation with embryo development, and recent studies coincide with our results. For example, [@bib38] found that embryo development gene DPPA2 is coexpressed with cancer testis antigens in non-small cell lung cancer, and some evidence show that developmental diseases are related with embryo development ([@bib63]). At the same time, we found some evidences to support the correlation between embryo development and disease in gene expression level ([@bib38], [@bib50], [@bib69]). All above these could certificate that embryo development and disease indeed have association and different kinds of disease have different relationship with embryo development. The result can imply that we can further investigate the pathogenesis of disease from perspective of similarity with embryo development, especially with high-related embryo development disease.

Previous investigations have demonstrated that different diseases tend to be co-morbid if they have a similar cellular mechanism, including component of the genome, transcriptome, proteome and metabolome in the pathogenesis ([@bib44]). We analyzed the effect of embryo development genes on disease co-morbidity using the data from [@bib54] studies, and found that there is a little difference in co-morbidity incidence of diseases between diseases, which share or not share embryo development genes. We used $\Phi$ to represent co-morbidity incidence of diseases (see [Section 2](#s0010){ref-type="sec"}). $\overline{\Phi} = 0.013$ for diseases that share embryo development genes, and 0.01 for diseases that do not share embryo development genes. It indicates that the diseases that share embryo development genes are apt to appearance together in the population.

Certainly, we noted that there is some potential bias in the source of data such as the preference of disease gene association and the incompleteness of embryo development genes. For instance, the co-morbidity incidences have no significant difference among three groups of diseases, whether or not they share embryo development genes. One explanation is that the metabolism may be another biological mechanism prompting disease co-morbidity ([@bib44]) besides embryo development. We carefully studied the metabolism-related diseases, and found that 66.5% of diseases belong to metabolism-related diseases. In addition to the influence induced by other biological mechanisms, a number of influences, such as the environmental factor, lifestyle and treatment-related factors, may also alter the impact of the correlation between embryo development and disease. Moreover, according to a recent comprehensive review ([@bib16]), to develop a useful model or predictor for biological systems, the following things were usually needed to consider: (i) benchmark dataset construction or selection, (ii) mathematical formulation for biological sequence samples, (iii) operating algorithm (or engine), (iv) anticipated accuracy and (v) web-server establishment. So we used the embryo development genes and disease genes to prove the relationship between embryo development and disease based on the steps that we mentioned above. Since user-friendly and publicly accessible web-servers represent the future direction for developing practically more useful models, simulated methods or predictors ([@bib19]), we shall make efforts in our future work to provide a web-server for the method presented in this paper. Meanwhile, with the development of high-throughput molecular biotechnology, especially mature application of the next-generation sequencing, we can further study the etiologies and pathobiologies of disease using embryo development process from systems biology viewpoint.
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===================================
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[^1]: Joint first authors.

[^2]: EHD genes, EMD genes and ELD genes display difference in GOA enrichment. *p*-values followed by "under" represent underrepresentation, while others mean overrepresentation.
